Characterization of genomic vitamin D receptor binding sites through chromatin looping and opening.

The vitamin D receptor (VDR) is a transcription factor that mediates the genomic effects of 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3). Genome-wide there are several thousand binding sites and hundreds of primary 1,25(OH)2D3 target genes, but their functional relation is largely elusive. In this study,...

Full description

Bibliographic Details
Main Authors: Sabine Seuter, Antonio Neme, Carsten Carlberg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3999108?pdf=render
_version_ 1819079864684118016
author Sabine Seuter
Antonio Neme
Carsten Carlberg
author_facet Sabine Seuter
Antonio Neme
Carsten Carlberg
author_sort Sabine Seuter
collection DOAJ
description The vitamin D receptor (VDR) is a transcription factor that mediates the genomic effects of 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3). Genome-wide there are several thousand binding sites and hundreds of primary 1,25(OH)2D3 target genes, but their functional relation is largely elusive. In this study, we used ChIA-PET data of the transcription factor CTCF in combination with VDR ChIP-seq data, in order to map chromatin domains containing VDR binding sites. In total, we found 1,599 such VDR containing chromatin domains and studied in THP-1 human monocytic leukemia cells four representatives of them. Our combined ChIP-seq and FAIRE-seq time course data showed that each of these four domains contained a master VDR binding site, where an increase of VDR binding pairs with 1,25(OH)2D3-promoted chromatin opening and the presence of a highly significant DR3-type sequence below the peak summit. These sites differed in their relative VDR binding but not in their kinetics, while other loci either had a weaker and delayed VDR association or could not be confirmed at all. All studied chromatin domains contained at least one primary 1,25(OH)2D3 target gene demonstrating a characteristic slope of mRNA increase, while neighboring genes responded delayed, if at all. In conclusion, the observation of ligand-inducible VDR binding and chromatin opening combined with a DR3-type sequence highlighted genome-wide 160 VDR loci that have within their chromatin domain a more than 4-fold increased likelihood to identify a primary 1,25(OH)2D3 target gene than in the vicinity of other genomic VDR binding sites.
first_indexed 2024-12-21T19:35:46Z
format Article
id doaj.art-b12b6de9b61f49868197b0ab45d754d5
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T19:35:46Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b12b6de9b61f49868197b0ab45d754d52022-12-21T18:52:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0194e9618410.1371/journal.pone.0096184Characterization of genomic vitamin D receptor binding sites through chromatin looping and opening.Sabine SeuterAntonio NemeCarsten CarlbergThe vitamin D receptor (VDR) is a transcription factor that mediates the genomic effects of 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3). Genome-wide there are several thousand binding sites and hundreds of primary 1,25(OH)2D3 target genes, but their functional relation is largely elusive. In this study, we used ChIA-PET data of the transcription factor CTCF in combination with VDR ChIP-seq data, in order to map chromatin domains containing VDR binding sites. In total, we found 1,599 such VDR containing chromatin domains and studied in THP-1 human monocytic leukemia cells four representatives of them. Our combined ChIP-seq and FAIRE-seq time course data showed that each of these four domains contained a master VDR binding site, where an increase of VDR binding pairs with 1,25(OH)2D3-promoted chromatin opening and the presence of a highly significant DR3-type sequence below the peak summit. These sites differed in their relative VDR binding but not in their kinetics, while other loci either had a weaker and delayed VDR association or could not be confirmed at all. All studied chromatin domains contained at least one primary 1,25(OH)2D3 target gene demonstrating a characteristic slope of mRNA increase, while neighboring genes responded delayed, if at all. In conclusion, the observation of ligand-inducible VDR binding and chromatin opening combined with a DR3-type sequence highlighted genome-wide 160 VDR loci that have within their chromatin domain a more than 4-fold increased likelihood to identify a primary 1,25(OH)2D3 target gene than in the vicinity of other genomic VDR binding sites.http://europepmc.org/articles/PMC3999108?pdf=render
spellingShingle Sabine Seuter
Antonio Neme
Carsten Carlberg
Characterization of genomic vitamin D receptor binding sites through chromatin looping and opening.
PLoS ONE
title Characterization of genomic vitamin D receptor binding sites through chromatin looping and opening.
title_full Characterization of genomic vitamin D receptor binding sites through chromatin looping and opening.
title_fullStr Characterization of genomic vitamin D receptor binding sites through chromatin looping and opening.
title_full_unstemmed Characterization of genomic vitamin D receptor binding sites through chromatin looping and opening.
title_short Characterization of genomic vitamin D receptor binding sites through chromatin looping and opening.
title_sort characterization of genomic vitamin d receptor binding sites through chromatin looping and opening
url http://europepmc.org/articles/PMC3999108?pdf=render
work_keys_str_mv AT sabineseuter characterizationofgenomicvitamindreceptorbindingsitesthroughchromatinloopingandopening
AT antonioneme characterizationofgenomicvitamindreceptorbindingsitesthroughchromatinloopingandopening
AT carstencarlberg characterizationofgenomicvitamindreceptorbindingsitesthroughchromatinloopingandopening